Physician profile
Austin Younger
NPI 1992068183
$17,912.98
in general payments reported to CMS, 2019-2025
34 companies · $37.26 in 2025
The $37.26 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $551 · 2021: $4,190 · 2022: $6,923 · 2023: $2,504 · 2024: $3,412 · 2025: $37.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,700 · Food and Beverage: $1,907 · Travel and Lodging: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,700.00 |
| Food and Beverage | $1,906.50 |
| Travel and Lodging | $346.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,079.00 | 2021-2023 | Da Vinci Surgical System |
| Olympus America INC. | $4,627.97 | 2022-2025 | Itind System, Soltive, Bovie |
| Teleflex LLC | $846.71 | 2021 | |
| Medtronic USA, INC. | $629.53 | 2019-2020 | |
| Medtronic, INC. | $568.04 | 2021-2024 | Interstim |
| Boston Scientific Corporation | $309.23 | 2019-2023 | |
| Abbvie INC. | $198.36 | 2022-2024 | Botox |
| Antares Pharma, INC. | $184.54 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $154.83 | 2021-2022 | |
| Neotract INC. | $129.50 | 2019 | |
| Endo Pharmaceuticals INC. | $123.59 | 2022-2024 | Xiaflex, Aveed |
| Karl Storz Endoscopy-America | $111.83 | 2023 | N.A. |
| Baxter Healthcare | $110.84 | 2024 | Floseal |
| Sumitomo Pharma America, INC. | $85.57 | 2023-2024 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $77.31 | 2022-2023 | Provenge |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $75.59 | 2021-2023 | Prolaris |
| Myovant Sciences INC. | $73.46 | 2022 | |
| Urogen Pharma, INC. | $60.82 | 2022-2023 | Jelmyto |
| Abc Home Medical Supply, INC. | $52.23 | 2022 | |
| Procept Biorobotics Corporation | $46.92 | 2024 | Aquabeam System |
| Astellas Pharma US INC | $46.42 | 2021-2022 | |
| Allergan, INC. | $44.17 | 2021-2022 | |
| Urovant Sciences INC | $35.12 | 2022 | |
| Accord Healthcare, INC. | $34.97 | 2022 | |
| 180 Medical, INC. | $27.14 | 2021 | |
| Coloplast Corp | $27.06 | 2021 | |
| Endo USA, INC. | $23.95 | 2024 | Xiaflex |
| Becton, Dickinson and Company | $22.14 | 2024 | Progel Applicator Spray Tips |
| Progenics Pharmaceuticals, INC. | $21.43 | 2023 | Pylarify |
| Pfizer INC. | $19.54 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.40 | 2023 | Givlaari |
| Mission Pharmacal Company | $17.24 | 2022 | |
| Ambu INC. | $15.33 | 2022 | |
| Telix Pharmaceuticals | $13.20 | 2023 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Younger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.